(Q37345699)

19 August 2017

1 reference

title

Symptom management in premenopausal patients with breast cancer (English)

1 reference

19 August 2017

1 reference

Charles L Loprinzi

1

1 reference

19 August 2017

Sherry L Wolf

series ordinal

2

1 reference

19 August 2017

Debra L Barton

series ordinal

3

1 reference

19 August 2017

Nadia Ni Laack

series ordinal

4

1 reference

19 August 2017

language of work or name

1 reference

1 October 2008

1 reference

Lancet Oncology Commission

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

10

1 reference

19 August 2017

993-1001

1 reference

A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Scatter dose estimation based on dose-area product and the specification of radiation barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Initial 17beta-estradiol dose for treating vasomotor symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III evaluation of fluoxetine for treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Gabapentin's effects on hot flashes and hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pilot evaluation of gabapentin for treating hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Hot flashes: behavioral treatments, mechanisms, and relation to sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Treatment of menopausal symptoms with applied relaxation: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Stellate-ganglion block: a new treatment for hot flushes?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Reduced thermoregulatory null zone in postmenopausal women with hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Evidence-based practice for symptom management in adults with cancer: sexual dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Treatment of urogenital atrophy with low-dose estradiol: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Web-based survey of fertility issues in young women with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Pregnancy after breast cancer: population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect"

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Egg retrieval with cryopreservation does not delay breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Effects of breast-conserving therapy on lactation after pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Breast-feeding after breast cancer in childbearing women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Inflammatory biomarkers for persistent fatigue in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Use of gabapentin to treat taxane-induced myalgias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

Cognitive-behavioral management of chemotherapy-related cognitive change

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970256-0

7 January 2021

10.1016/S1470-2045(08)70256-0

Identifiers

DOI

1 reference

release_s4dtftyfmfbqfevcfdrsvbgt3y

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s4dtftyfmfbqfevcfdrsvbgt3y

24 November 2022

mapped directly with Wikidata item

1 reference